+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Zoster Vaccine"

Global Shingles Vaccine Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Global Shingles Vaccine Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Middle East & Africa Vaccines Market Outlook, 2028 - Product Thumbnail Image

Middle East & Africa Vaccines Market Outlook, 2028

  • Report
  • September 2023
  • 87 Pages
  • Middle East, Africa
From
Europe Vaccines Market Outlook, 2028 - Product Thumbnail Image

Europe Vaccines Market Outlook, 2028

  • Report
  • September 2023
  • 112 Pages
  • Europe
From
From
Vaccinations - Product Thumbnail Image

Vaccinations

  • Book
  • November 2018
  • 12 Results (Page 1 of 1)
Loading Indicator

The Zoster Vaccine is a vaccine used to prevent shingles, a painful and debilitating condition caused by the varicella-zoster virus. It is recommended for adults over the age of 50, and is available in both single-dose and two-dose formulations. The vaccine is highly effective in preventing shingles, and can also reduce the severity of symptoms in those who do develop the condition. It is also recommended for those who have had chickenpox in the past, as they are at higher risk of developing shingles. The Zoster Vaccine market is a subset of the larger Vaccines market, which includes a wide range of products used to prevent and treat infectious diseases. The Zoster Vaccine market is relatively small compared to other vaccine markets, but is growing as more people become aware of the risks associated with shingles. Some companies in the Zoster Vaccine market include Merck, GlaxoSmithKline, Sanofi Pasteur, and Pfizer. Show Less Read more